Bavarian Nordic

Bavarian Nordic Improving and saving lives through innovative vaccines is at the heart of what we do at Bavarian Nordic. For us, it is all about improving and saving lives.

We are a fully integrated vaccine company, focused on the development, manufacturing, and commercialization of our vaccines Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and co

mmercialization of our vaccines. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the public health preparedness and have a strong portfolio of vaccines for travelers and endemic diseases. Our values – our Bavarian Nordic DNA, as we call it – is what guides our actions. We act as persistent pioneers, we are embracing change, we value being boosted by the team, and we believe in protecting lives every day. If that is also a part of your DNA, we invite you to join us in Bavarian Nordic! We are a global team of more than 1,400 dedicated people with diverse backgrounds and viewpoints who are bound together by our commitment to protect lives every day. We believe in creating an inclusive and flexible workplace with a strong focus on personal and professional development, because we need each other to take things further. We operate in a world in constant flux and always explore new opportunities. So, if you are open-minded and have the willpower to succeed, we might just be a perfect fit. See your career opportunities at www.bavarian-nordic.com/careers

13/05/2026

Our Q1 2026 results are out – and they confirm the strength of our business. 👇

🌍 Travel Health delivered strong growth, driven by sustained demand and our continued focus on organic growth in existing markets

🛡️ Public Preparedness performed in line with expectations in a more normalized environment following years of outbreak‑driven demand

Within Travel Health, our chikungunya vaccine continues to gain traction, while our rabies vaccine remains a key growth driver.

📈 Following a new contract from the US government for the production and supply of smallpox vaccines, we have upgraded our full‑year guidance to DKK 5,500–5,700 million and an EBITDA margin of approximately 28%.

We are proud of the trust placed in our company and our vaccines. That trust from customers, governments and partners reflects the continued need for our vaccines – and the role we play in helping safeguard communities against emerging threats.

Explore the key Q1 2026 figures in the video below.

27/04/2026

This week, we join the global community in marking World Immunization Week.

Under the World Health Organization theme "For every generation, vaccines work", this week highlights how vaccines continue to protect people, families and communities, and why they remain essential to the future of public health.

Hear from our colleagues, watch the video and join the conversation.

12/03/2026

Our 2025 Annual Report, including our Sustainability Statement, is now live 📊🌍

Here are a few highlights:
📈Our final financial results remain in line with the preliminary results previously announced.
🛡️ We helped protect people and communities across 30+ countries
💉 1.3 million mpox vaccine doses delivered to communities affected by outbreaks through partnerships, including a donation of 130,000 doses.
🍃 Our Danish manufacturing site is powered by 100% renewable energy.
🤍 Our global team grew by 11%, and we achieved 50% gender representation in top management.

A huge thank you to our colleagues and partners around the world who make this impact possible.

Curious to learn more? Dive into the full report here: https://brnw.ch/21x0FuD

#2025

22/02/2026

Emily was only 13 when a single tick bite changed her life.

In the video below, her father Dirk Abel shares the moment she contracted Tick-Borne Encephalitis (TBE) - an event that turned their family’s world upside down. Their story is honest and deeply personal, and a reminder that TBE doesn’t discriminate. It can affect anyone, at any age.

TBE is a viral infection transmitted by ticks and found in many parts of Europe.

In partnership with Encephalitis International, we invite you to take a moment to learn more - because awareness and prevention matter more than we often realise.

Speak to a healthcare professional for further information or learn more here: https://brnw.ch/21x09yL

18/02/2026

A simple tick bite can cause serious brain inflammation, but do you know the symptoms to look out for?

Most of us spend time outdoors. Many of us have seen ticks.
But very few people know that a tick bite can lead to Tick-Borne Encephalitis, a serious brain infection that is often misunderstood, or not known at all.

That’s why, in the leadup to , we are taking a moment to focus on the symptoms to look out for. Encephalitis International has developed the acronym F.L.A.M.E.S that reflects the urgent neurological signs that the general public and healthcare professionals should be aware of to help recognize encephalitis earlier.

Together with our partner Encephalitis International we are raising awareness and helping more people feel informed and protected.

Want to make a difference? Watch the video and help raise awareness by spreading the word.

Speak to a healthcare professional for further information or learn more here: https://brnw.ch/21x02Ls


13/02/2026

2025 in review: what made it a standout year.

Last year, our teams worked tirelessly to deliver strong results - and we’re proud to say we exceeded expectations across the board.

Still, what truly defines 2025 is the impact behind those numbers. Each achievement strengthens our ability to protect and save lives around the world.

🎥 In this video, CFO Henrik Juuel shares his reflections on what drove our 2025 performance and what we’re looking ahead to in 2026. We invite you to watch and hear his perspective firsthand.

You can read the full company announcement via the link in the comments.

12/02/2026

We’re proud to share our preliminary financial results for 2025. A company performance that exceeded expectations while continuing to protect millions of people globally each year. Our work reinforces our shared purpose: saving lives with life-changing vaccines.

Looking ahead to 2026, we anticipate continued growth in travel health and a return to more normalized public preparedness activity after several years of outbreak-driven demand. We remain focused on disciplined ex*****on, building commercial momentum, and creating long-term value.

🎥 Watch the video below for key financial highlights from 2025 and our outlook for 2026.

Looking for more details? Read the full announcement via the link in the comments.

30/01/2026

Flight booked? Check. Sunscreen packed? Check. Spoke to a travel health provider about travel health? ...Wait, what?

We often think about common travel diseases when planning a trip but neglected tropical diseases (NTDs) should not be forgotten.

On World Neglected Tropical Diseases Day, we are talking about the things that often don’t make your packing list but probably should.

Chikungunya is one of more than 21 NTDs that many travelers haven’t even heard of. It is a mosquito-borne disease, and it is spreading. So, whether you are chasing sunsets in the Caribbean, spotting wildlife in Africa, or traveling for business to Southeast Asia, if infected mosquitoes are around, you may be on their radar.

The first step to help protect yourself is knowledge. That is why we unite and act together with the The International Society for Neglected Tropical Diseases (ISNTD) to support World Health Organization (WHO)'s efforts to control and eliminate NTDs.

So, before you zip up that suitcase, add one more item to your checklist: knowledge. It weighs nothing, but it can make all the difference.

Did you know that encephalitis is an inflammation of the brain? Some forms of encephalitis, such as tick-borne encephali...
22/02/2023

Did you know that encephalitis is an inflammation of the brain? Some forms of encephalitis, such as tick-borne encephalitis (TBE), can be prevented by vaccination.

Today, we announced the signing of a joint procurement agreement with HERA, the European Commission’s Health Emergency P...
17/11/2022

Today, we announced the signing of a joint procurement agreement with HERA, the European Commission’s Health Emergency Preparedness and Response Authority for the supply of up to 2 million doses of monkeypox vaccine during 2023 and 2024.

Read full announcement: https://www.bavarian-nordic.com/investor/news/news.aspx?news=6658

Adresse

Hellerup

Internet side

Underretninger

Vær den første til at vide, og lad os sende dig en email, når Bavarian Nordic sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Genveje

Del

Type